{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-29",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "0781-2495",
      "generic_name": "nintedanib",
      "labeler_name": "Sandoz Inc",
      "brand_name": "nintedanib",
      "active_ingredients": [
        {
          "name": "NINTEDANIB ESYLATE",
          "strength": "150 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "0781-2495-60",
          "description": "60 CAPSULE in 1 BOTTLE (0781-2495-60)",
          "marketing_start_date": "20260402",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Sandoz Inc"
        ],
        "rxcui": [
          "1592742",
          "1592750"
        ],
        "spl_set_id": [
          "751c3473-35d6-47d6-b405-af16a989716c"
        ],
        "is_original_packager": [
          true
        ],
        "unii": [
          "42F62RTZ4G"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "CAPSULE",
      "spl_id": "93bd44f8-ed32-4607-8d02-56a219263dd4",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260402",
      "product_id": "0781-2495_93bd44f8-ed32-4607-8d02-56a219263dd4",
      "application_number": "ANDA216915",
      "brand_name_base": "nintedanib",
      "pharm_class": [
        "Kinase Inhibitor [EPC]",
        "Protein Kinase Inhibitors [MoA]"
      ]
    }
  ]
}